Finance

Lists
544172:BOM
Indegene Ltd
₹544.45
+5.74%
(+29.55) 1D
Aug 3, 3:53:55 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 544172...
Open
₹526.25
High
₹554.00
Low
₹512.70
Mkt. cap
130.46B
Avg. vol.
52.17K
Volume
59.20K
Dividend
0.41%
Quarterly dividend
₹0.56
Ex-dividend date
Jul 31, 2026
P/E ratio
32.76
52-wk high
₹596.50
52-wk low
₹414.90
EPS
₹16.62
No. of employees
5K
Open
₹526.25
High
₹554.00
Low
₹512.70
Mkt. cap
130.46B
Avg. vol.
52.17K
Volume
59.20K
Dividend
0.41%
Quarterly dividend
₹0.56
Ex-dividend date
Jul 31, 2026
P/E ratio
32.76
52-wk high
₹596.50
52-wk low
₹414.90
EPS
₹16.62
No. of employees
5K
News stories
From sources across the web
Profile
Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises. Based in Bangalore, the company provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics. Wikipedia
About Indegene Ltd
CEOManish Gupta
Employees4.69K
Founded1998
Headquarters-
SectorHealth care
Websiteindegene.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
8.04B
9.42B
10.03B
10.63B
Cost of goods sold
-
-
778.00M
-
Cost of revenue
-
-
778.00M
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.16B
5.68B
6.39B
-
Operating expense
6.87B
8.22B
7.99B
-
Total operating expenses
6.87B
8.22B
8.77B
-
Operating income
1.17B
1.20B
1.26B
-
Other non operating income
197.00M
194.00M
-620.00M
-
EBT including unusual items
1.33B
1.35B
1.05B
-
EBT excluding unusual items
1.33B
1.35B
944.00M
-
Income tax expense
310.00M
318.00M
254.00M
-
Effective tax rate
23.29%
23.61%
24.17%
-
Other operating expenses
1.48B
2.15B
1.18B
-
Net income
1.02B
1.03B
797.00M
-
Net profit margin
12.70%
10.92%
7.94%
10.93%
Earnings per share
4.23
4.26
3.94
4.81
Interest and investment income
-
-
363.00M
-
Interest expense
-38.00M
-46.00M
-39.00M
-
Net interest expenses
-38.00M
-46.00M
324.00M
-
Depreciation and amortization charges
234.00M
396.00M
418.00M
-
EBITDA
1.40B
1.33B
1.49B
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps